MX9606041A - Fast dissolving dosage forms. - Google Patents

Fast dissolving dosage forms.

Info

Publication number
MX9606041A
MX9606041A MX9606041A MX9606041A MX9606041A MX 9606041 A MX9606041 A MX 9606041A MX 9606041 A MX9606041 A MX 9606041A MX 9606041 A MX9606041 A MX 9606041A MX 9606041 A MX9606041 A MX 9606041A
Authority
MX
Mexico
Prior art keywords
fast dissolving
dosage forms
dissolving dosage
fast
nonrupturable
Prior art date
Application number
MX9606041A
Other languages
Spanish (es)
Other versions
MXPA96006041A (en
Inventor
Michelle Elizabeth Brideau
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Priority claimed from PCT/US1995/006855 external-priority patent/WO1995033446A1/en
Publication of MXPA96006041A publication Critical patent/MXPA96006041A/en
Publication of MX9606041A publication Critical patent/MX9606041A/en

Links

Abstract

A nonrupturable, fast dissolving, taste masking composition providing immediate release of pharmaceutically acceptable active ingredients.
MX9606041A 1995-05-31 1995-05-31 Fast dissolving dosage forms. MX9606041A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US253890 1994-06-03
PCT/US1995/006855 WO1995033446A1 (en) 1994-06-03 1995-05-31 Fast dissolving dosage forms

Publications (2)

Publication Number Publication Date
MXPA96006041A MXPA96006041A (en) 1998-02-01
MX9606041A true MX9606041A (en) 1998-02-28

Family

ID=39165200

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9606041A MX9606041A (en) 1995-05-31 1995-05-31 Fast dissolving dosage forms.

Country Status (1)

Country Link
MX (1) MX9606041A (en)

Similar Documents

Publication Publication Date Title
MX9602683A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances.
EP0828481A4 (en) Oral dosage composition for intestinal delivery and method of use of the same
TWI235068B (en) Sustained-release pharmaceutical composition
CA2259148A1 (en) Solid oral dosage forms of valsartan
IL120382A (en) Extended release formulation of venlafaxine hydrochloride
AU1227899A (en) Osmotic medicament releasing system
YU33099A (en) Pharmaceutical composition
MY129356A (en) Electrospun pharmaceutical compositions
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
MX9605023A (en) Imidazolidine-2,4-dione substituted compounds, as pharmaceutically active substances.
CA2427815A1 (en) Controlled release hydrocodone formulations
PT893992E (en) FORMS OF FAST DISINTEGRATION ORAL DOSAGE
AU5651696A (en) Substituted 1-phenyl-3-pyrazolecarboxamides active on nurotensin receptors, their preparation and pharmaceutical compositions containing them
NZ298769A (en) use of progesterone-antagonistic and anti-estrogen compounds in a single dose for female contraception
CA2294783A1 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
CA2622805A1 (en) Compressed tablets comprising valsartan
NZ504460A (en) Sustained release formulations containing venlafaxine
CA2325739A1 (en) Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator
HK1039273A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
HRP20010684B1 (en) Directly compressible matrix for controlled release of single daily doses of clarithromycin
IL150528A0 (en) Ibuprofen containing active agent preparation
MX9603606A (en) N-methyl-n-[(1s)-1-phenyl-2-((3s)-3-hydroxypirrolidin-1-yl)ethyl]-2,2-di phenyl-acetamide.
WO2002015933A3 (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
MX9708394A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation.
ZA966047B (en) Therapeutic agents.